1. Home
  2. Analysis
  3. Creatine
  4. Latuda

Creatine and Latuda drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Creatine (creatine) and Latuda (lurasidone hydrochloride). Common drug interactions include pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Creatine and Latuda. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Creatine?

Creatine has active ingredients of creatine. It is often used in muscle mass. eHealthMe is studying from 1,390 Creatine users. Check the latest studies of Creatine.

What is Latuda?

Latuda has active ingredients of lurasidone hydrochloride. It is often used in bipolar disorder. eHealthMe is studying from 21,543 Latuda users. Check the latest studies of Latuda.

On Jul, 18, 2026

12 people who take Creatine and Latuda together, and have interactions are studied.

Creatine and Latuda drug interactions.

What are the common drug interactions of Creatine and Latuda, by gender? *:

female:

n/a

male:

  1. Pneumonia
  2. Pyrexia (fever)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Spinal cord injury
  5. Abdominal discomfort
  6. Adverse event
  7. Respiratory disorder (respiratory disease)
  8. Death
  9. Diarrhoea
  10. Dysphagia (a condition in which swallowing is difficult or painful)

What are the common drug interactions of Creatine and Latuda, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Diarrhoea
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Oxygen saturation decreased
  4. Pain
  5. Pyrexia (fever)
  6. Sputum increased
  7. Urinary tract infection

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 12 people, 100.00%
  2. Combined Immunodeficiency: 6 people, 50.00%
  3. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 4 people, 33.33%
  4. Primary Immunodeficiency Syndrome: 3 people, 25.00%
  5. Immunodeficiency: 2 people, 16.67%
  6. Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Creatine and Latuda?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Creatine and Latuda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Creatine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Latuda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Creatine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Latuda and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on creatine and lurasidone hydrochloride (the active ingredients of Creatine and Latuda, respectively), and Creatine and Latuda (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.